Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.

Abstract excerpt

Cystic fibrosis (CF) is the most common life-shortening genetic disease affecting ~1 in 3,500 of the Caucasian population. CF is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. To date, more than 2,000 CFTR mutations have been identified, which produce a wide range of phenotypes. The CFTR protein, a chloride channel, is normally expressed on epithelial cells lining the lung, gut,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chloride Channel Agonists
• Share to Cystic Fibrosis